SymBio Pharmaceuticals
Latest round
- Series E
Last raised
- Feb 2011
Total raised
- $80M
Investors
- 15
About SymBio Pharmaceuticals
SymBio Pharmaceuticals Limited was founded in 2005 and is headquartered in Tokyo, Japan. The company specializes in biopharmaceutical development and has engaged in 10 notable deals, with its most recent deal occurring on May 16, 2022.SymBio Pharmaceuticals Limited specializes in the development and commercialization of biopharmaceutical products aimed at addressing unmet medical needs, particularly in oncology. Their flagship product, TREAKISYM (bendamustine hydrochloride), is used for treating relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. This product disrupts cancer cell DNA, leading to cell death.5. The company generates revenue through direct sales to healthcare institutions and pharmaceutical distributors, utilizing a B2B transaction model where TREAKISYM is supplied under contractual agreements.SymBio Pharmaceuticals Limited plans to leverage the recent investment of JPY 662 million from Heights Capital Management, expected to enhance growth opportunities. The company is focused on developing and launching new products, although specific details and timelines have not been disclosed. Additionally, there are intentions to expand into new geographic markets, aiming to reach broader patient demographics. The investment will play a crucial role in supporting these initiatives.
Who invested in SymBio Pharmaceuticals
15 investors across 5 rounds
See all investors in SymBio Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SymBio Pharmaceuticals
Who invested in SymBio Pharmaceuticals?
SymBio Pharmaceuticals has 15 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SymBio Pharmaceuticals raised?
SymBio Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did SymBio Pharmaceuticals last raise money?
SymBio Pharmaceuticals's most recent round on record is a Series E, in Feb 2011.
What does SymBio Pharmaceuticals do?
SymBio Pharmaceuticals Limited was founded in 2005 and is headquartered in Tokyo, Japan.
Where is SymBio Pharmaceuticals headquartered?
SymBio Pharmaceuticals is headquartered in Tokyo, Japan.
Which VCs invest in companies like SymBio Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at SymBio Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like SymBio Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.